Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways

被引:74
作者
Carpio, L [1 ]
Gladu, J [1 ]
Goltzman, D [1 ]
Rabbani, SA [1 ]
机构
[1] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2001年 / 281卷 / 03期
关键词
parathyroid hormone-related peptide; osteoblast; cell differentiation; hypercalcemia;
D O I
10.1152/ajpendo.2001.281.3.E489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parathyroid hormone (PTH)-related peptide (PTHrP) can modulate the proliferation and differentiation of a number of cell types including osteoblasts. PTHrP can activate a G protein-coupled PTH/PTHrP receptor, which can interface with several second-messenger systems. In the current study, we have examined the signaling pathways involved in stimulated type I collagen and alkaline phosphatase expression in the human osteoblast-derived osteosarcoma cells, MG-63. By use of Northern blotting and histochemical analysis, maximum induction of these two markers of osteoblast differentiation occurred after 8 h of treatment with 100 nM PTHrP-(1-34). Chemical inhibitors of adenylate cyclase (H-89) or of protein kinase C (chelerythrine chloride) each diminished PTHrP-mediated type I collagen and alkaline phosphatase stimulation in a dose-dependent manner. These effects of PTHrP could also be blocked by inhibiting the Ras-mitogen-activated protein kinase (MAPK) pathway with a Ras farnesylation inhibitor, B1086, or with a MAPK inhibitor, PD-98059. Transient transfection of MG-63 cells with a mutant form of Galpha, which can sequester beta gamma-subunits, showed significant downregulation of PTHrP-stimulated type I collagen expression, as did inhibition of phosphatidylinositol 3-kinase (PI 3-kinase) by wortmannin. Consequently, the beta gamma-PI 3-kinase pathway may be involved in PTHrP stimulation of Ras. Collectively, these results demonstrate that, acting via its G protein-coupled receptor, PTHrP can induce indexes of osteoblast differentiation by utilizing multiple, perhaps parallel, signaling pathways.
引用
收藏
页码:E489 / E499
页数:11
相关论文
共 44 条
[1]   EXPRESSION CLONING OF A COMMON RECEPTOR FOR PARATHYROID-HORMONE AND PARATHYROID HORMONE-RELATED PEPTIDE FROM RAT OSTEOBLAST-LIKE CELLS - A SINGLE RECEPTOR STIMULATES INTRACELLULAR ACCUMULATION OF BOTH CAMP AND INOSITOL TRISPHOSPHATES AND INCREASES INTRACELLULAR FREE CALCIUM [J].
ABOUSAMRA, AB ;
JUPPNER, H ;
FORCE, T ;
FREEMAN, MW ;
KONG, XF ;
SCHIPANI, E ;
URENA, P ;
RICHARDS, J ;
BONVENTRE, JV ;
POTTS, JT ;
KRONENBERG, HM ;
SEGRE, GV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2732-2736
[2]  
Aklilu F, 2000, CANCER RES, V60, P1753
[3]  
AUBIN JE, 1995, BONE, V17, P77
[4]   WHICH G-PROTEIN SUBUNITS ARE THE ACTIVE MEDIATORS IN SIGNAL TRANSDUCTION [J].
BIRNBAUMER, L .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (06) :209-211
[5]   IMMUNOCHEMICAL CHARACTERIZATION OF CIRCULATING PARATHYROID-HORMONE RELATED PROTEIN IN PATIENTS WITH HUMORAL HYPERCALCEMIA OF CANCER [J].
BURTIS, WJ ;
BRADY, TG ;
ORLOFF, JJ ;
ERSBAK, JB ;
WARRELL, RP ;
OLSON, BR ;
WU, TL ;
MITNICK, ME ;
BROADUS, AE ;
STEWART, AF .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (16) :1106-1112
[6]   Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of delta-opioid receptors [J].
Cai, YC ;
Ma, L ;
Fan, GH ;
Zhao, J ;
Jiang, LZ ;
Pei, G .
MOLECULAR PHARMACOLOGY, 1997, 51 (04) :583-587
[7]   DIFFERENTIAL-EFFECTS OF CONTINUOUS AND TRANSIENT TREATMENT WITH PARATHYROID-HORMONE RELATED PEPTIDE (PTHRP) ON BONE-COLLAGEN SYNTHESIS [J].
CANALIS, E ;
MCCARTHY, TL ;
CENTRELLA, M .
ENDOCRINOLOGY, 1990, 126 (04) :1806-1812
[8]  
CARTER AN, 1992, P NATL ACAD SCI USA, V88, P7908
[9]   Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence [J].
Choi, HJ ;
Hyun, MS ;
Jung, GJ ;
Kim, SS ;
Hong, SH .
ONCOLOGY, 1998, 55 (06) :575-581
[10]   G protein beta gamma subunits [J].
Clapham, DE ;
Neer, EJ .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :167-203